Gestational Hypertension: When First-Line Antihypertensive Monotherapy Has Not Reached the Target
This protocol applies to non-severe gestational hypertension — de novo hypertension arising at or after 20 weeks' gestation — where initial single-agent therapy has been optimised but the blood pressure target has not been achieved.
Clinical Scenario
Blood pressure is in the non-severe range: systolic BP below 160 mmHg and diastolic BP below 110 mmHg. The hypertension has arisen de novo at ≥20 weeks' gestation, in the absence of proteinuria or other features suggesting pre-eclampsia.
Why This Protocol Applies
First-line oral antihypertensive monotherapy — with methyldopa, labetalol, or nifedipine, titrated toward a target diastolic BP of 85 mmHg — has not achieved that goal. Failure to reach the diastolic target is the clinical trigger for escalation to this next step.
Next Step — Partial Overview
The approach at this stage involves introducing a second antihypertensive agent from a different drug class, used alongside the initial first-line agent. The complete selection criteria, sequencing, and management algorithm are defined in the full protocol.
Treatment goal: A diastolic BP of 85 mmHg, regardless of systolic BP.
References
DOI: 10.1016/j.preghy.2021.09.008
- Hypertension arising de novo at ≥ 20 weeks’ gestation in the absence of proteinuria or other findings suggestive of pre-eclampsia
- Hypertension in pregnancy continues to be defined as a clinic sBP ≥ 140 mmHg and/or a dBP ≥ 90 mmHg, with sBP ≥ 160 mmHg and/or a dBP ≥ 110 mmHg defined as severe hypertension.
- Non-severe hypertension should be treated with the first-line agents oral methyldopa, labetalol, or nifedipine (⊕⊕⊕O/Strong).
- Additional antihypertensive drugs should be used if target BP levels are not achieved with standard-dose monotherapy, at least to a mid-range dose; add-on drugs should be from a different drug class chosen from first-line or second-line options.
- Less commonly-used but acceptable second-line antihypertensive agents include other beta-blockers (e.g., metoprolol).
- The target BP for antihypertensive therapy should be a dBP of 85 mmHg, regardless of sBP (⊕⊕⊕⊕/Strong).
View source ↗